Browsing: Merck
By Dan Levine and Mike Spector (Reuters) – Robert F. Kennedy Jr. would retain legal fees earned from litigation against…
By Dan Levine and Mike Spector (Reuters) – Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation…
Trump bump may be over as US stocks get slammed on Friday. Pharmaceutical stocks like Amgen and Merck have both…
By Leroy Leo (Reuters) -Merck has licensed an early-stage cancer drug from a China-based biotech in an up to $3.3…
By Michael Erman (Reuters) – Merck & Co posted higher-than-expected third-quarter earnings on Thursday on strong sales of its blockbuster…
Centers for Medicare & Medicaid Services issued new details about drug negotiations. Dow slides on expected further hostilities between Israel…
Check out the companies making headlines in premarket trading. CrowdStrike — Shares slipped 5% after CNBC reported that stated Delta…
Merck beats earnings expectations, raises sales outlook on strong demand for top drugs like Keytruda
Merck on Tuesday reported second-quarter revenue and adjusted earnings that topped Wall Street’s expectations as it saw strong sales from…
The Food and Drug Administration on Monday approved Merck’s new vaccine designed to protect adults from a bacteria known as…
Check out the companies making headlines before the bell: Meta Platforms — The Facebook parent company plunged more than 14%…